Moolchand Medcity, a premier healthcare institution headquartered in New Delhi, India, has been a cornerstone of the medical industry since its inception in 1993. Renowned for its comprehensive range of services, Moolchand operates across various regions, providing exceptional healthcare solutions in areas such as cardiology, orthopaedics, and oncology. With a commitment to innovation and patient care, Moolchand Medcity offers state-of-the-art facilities and advanced medical technologies, setting it apart in the competitive healthcare landscape. The institution has achieved numerous accolades, solidifying its position as a leader in the industry. Moolchand's dedication to excellence and patient-centric approach continues to redefine healthcare standards in India and beyond.
How does Moolchand Medcity's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Moolchand Medcity's score of 10 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Moolchand Medcity reported total carbon emissions of approximately 6,748,000 kg CO2e for Scope 1 and about 39,413,000 kg CO2e for Scope 2. This reflects a slight increase in emissions compared to 2022, where Scope 1 emissions were about 6,031,000 kg CO2e and Scope 2 emissions were approximately 36,686,000 kg CO2e. The data indicates that Moolchand Medcity has disclosed emissions for both Scope 1 and Scope 2 but has not reported any Scope 3 emissions. Despite the lack of specific reduction targets or initiatives, Moolchand Medcity is committed to addressing its carbon footprint. The organisation has not inherited emissions data from any parent company, indicating that its emissions reporting is independent. The total Scope 1 and Scope 2 emission intensity in terms of physical output was reported at 4.4 in 2023 and 4.2 in 2024, suggesting a focus on improving efficiency. Overall, while Moolchand Medcity has not set formal reduction targets, its emissions data highlights the need for ongoing monitoring and potential future commitments to climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 6,031,000 | 0,000,000 |
| Scope 2 | 36,686,000 | 00,000,000 |
| Scope 3 | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Moolchand Medcity has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
